Previously, we had reported a genome-wide scan for attention-deficit/hyperactivity disorder (ADHD) in 102 families with affected sibs of German ancestry; the highest multipoint LOD score of 4.75 was obtained on chromosome 5p13 (parametric HLOD analysis under a dominant model) near the dopamine transporter gene (DAT1). We genotyped 30 single nucleotide polymorphisms (SNPs) in this candidate gene and its 5 0 region in 329 families (including the 102 initial families) with 523 affected offspring. We found that (1) SNP rs463379 was significantly associated with ADHD upon correction for multiple testing (P = 0.0046); (2) the global P-value for association of haplotypes was significant for block two upon correction for all (n = 3) tested blocks (P = 0.0048); (3) within block two we detected a nominal P = 0.000034 for one specific marker combination. This CGC haplotype showed relative risks of 1.95 and 2.43 for heterozygous and homozygous carriers, respectively; and (4) finally, our linkage data and the genotype-IBD sharing test (GIST) suggest that genetic variation at the DAT1 locus explains our linkage peak and that rs463379 (P < 0.05) is the only SNP of the above haplotype that contributed to the linkage signal. In sum, we have accumulated evidence that genetic variation at the DAT1 locus underlies our ADHD linkage peak on chromosome 5; additionally solid association for a single SNP and a haplotype were shown. Future studies are required to assess if variation at this locus also explains other positive linkage results obtained for chromosome 5p.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is one of the most heritable disorders in child and adolescent psychiatry; heritability is estimated at approximately 0.8; 1,2 both linkage and association studies have been conducted. The most promising linkage region is distal chromosome 5p. In our previously reported genome-wide scan for ADHD, parametric heterogeneity LOD (HLOD) analysis under a dominant model yielded the highest multipoint LOD score of 4.75 on chromosome 5p13. 3 A metaanalysis of genome-wide linkage data on 424 sib pairs affected with ADHD from two previously published genome-wide scans [4] [5] [6] also suggests a common risk locus at 5p13. 7 To date, the best-known candidate gene for ADHD located on distal chromosome 5p is the dopamine transporter gene (DAT1, SLC6A3).
DAT1 regulates dopamine (DA) transmission by removing DA from extracellular spaces and recycling it back into DA neurons. 8 Several lines of evidence imply that dysregulation in DA transmission, particularly altered DAT1 function, is likely to be involved in the pathophysiology of ADHD: (1) Increased striatal DAT1 density has been found in imaging studies in both adults [9] [10] [11] and in children with ADHD; 12 however, van Dyck et al. 13 did not replicate these findings likely due to a different tracer with less binding specificity for DAT1. (2) Stimulants, effective in the treatment of the core symptoms of ADHD, are known to interact with DAT1; 14 striatal DAT1 availability is lowered effectively in children and adults with ADHD by methylphenidate in clinical doses. 9, 11 (3) Complete disruption of the DAT1 gene in mice (Dat1-knockout (KO) mice) alters DA tone and signaling and leads to spontaneous locomotor activity in novel environment and lack of locomotor habituation; [15] [16] [17] furthermore, Dat1-KO mice show deficits in learning, memory and social interactions leading to the hypothesis that Dat1-KO mice represent a model for ADHD. 18, 19 The DAT1 gene, encoding 620 amino acids, comprises 15 exons that span more than 52 kb of genomic DNA on human chromosome 5p15.33. DAT1 5 0 untranslated (UTR) and flanking regions show a low evolutionary structural similarity between mouse and human (http://genome.ucsc.edu). The DAT1 5 0 flanking region is characterized by the lack of TATA and CAAT boxes, a high GC content, TATA-like sequences and binding sites for transcription factors (i.e., Sp1, Sp3, Nurr1 [20] [21] [22] ). Common haplotypes in the DAT1 5 0 flanking region were described by different groups. 20, [23] [24] [25] [26] Eight haplotypes based on six single nucleotide polymorphisms (SNPs) that differ significantly in activity (up to 37%) in in vitro reporter gene assays have been described. 25 Another recent study 26 described a core haplotype composed of two SNPs, albeit different from those reported by Kelada et al. 25 that were associated with varying expression levels in vivo and, consistent with these data, in postmortem brain samples. These SNPs were rs2937639 ( þ 1821G > A) located in intron 1 and rs2652511 (À841C > T) in the 5 0 flanking region. To date, four studies have screened the coding region and splice junctions in DAT1 for genetic variation. [27] [28] [29] [30] Two of these studies, 29, 30 that also included ADHD patients in addition to patients with other neuropsychiatric disorders, described novel synonymous and intronic variants; however, polymorphisms associated with ADHD were not detected. Mazei-Robinson et al. 30 observed the nonsynonymous mutation A559V that had been described previously in an individual with bipolar disorder 28 in two affected sibs with ADHD. However, nonsynonymous mutations in the DAT1 have only rarely been identified; they thus cannot be etiologically relevant for the majority of individuals with the respective disorder.
In ADHD, a 40 bp repeat element (VNTR; variable number of tandem repeats) in the 3 0 UTR region of DAT1 29 has previously been the main focus of investigation as it purportedly is a regulatory element. The VNTR comprises repeat numbers ranging from 3-11 copies. The 9-and the 10-repeat alleles have been implicated in a variety of neuropsychiatric disorders. Cook et al. 31 first reported an association of the 10-repeat allele with ADHD. This association has been supported by others, 32, 33 but not all studies. [34] [35] [36] Two meta-analyses showed no significant association (P = 0.21 and P = 0.20) of the 3 0 VNTR with ADHD. 37, 38 Importantly, the 5 0 and 3 0 regions of the DAT1 locus are separated by a recombinational 'hot spot' between exons 7 and 9. The 3 0 VNTR shows strong linkage disequilibrium (LD) with variants in exons 9-15, but there is no reported with haplotypes in the first exons or the 5 0 flanking region. 39, 40 A recent publication 41 described the investigation of 32 SNPs in the genomic region of DAT1 in a sample of 663 families with at least one offspring with ADHD combined type (Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV)). They defined four haplotype blocks (HB): HB1: promoter-intron 2, HB2: intron 2-exon 8, HB3: intron 8-intron 13 and HB4: 3 0 UTR. These strongly overlap with blocks defined earlier in a bipolar sample. 24 Brookes et al. 41 detected six SNPs with nominal P < 0.05 for association with ADHD located in the 5 0 and 3 0 regions of the gene (HB1 and HB4), suggesting that, beside the frequently investigated 3 0 region, the 5 0 region of the gene might also be involved in the etiology of ADHD.
We hypothesized that genetic variation at the DAT1 locus substantially contributed to our previously reported linkage peak on distal chromosome 5p. 3 To increase the statistical power to detect a genetic association, we enlarged our sample to 329 families comprising at least one offspring with ADHD. Here we report the fine mapping of DAT1 and family-based association studies for 30 SNPs and haplotypes covering the 5 0 region, the coding sequence (CDS) and the 3 0 flanking region. We provide evidence for association of a DAT1 SNP and DAT1 haplotypes with ADHD and show that this association presumably underlies our previously reported linkage peak on chromosome 5p. 3 
Materials and methods

Sample description
We enlarged our previously described sample of 102 families. 3 In total, 329 ADHD families were ascertained and phenotypically characterized (Table 1 ) by physicians in six child psychiatric outpatient units (Aachen, Marburg, Homburg, Trier, Regensburg and Wuerzburg). Families were included if at least one child was diagnosed with ADHD according to DSM-IV. 42 In 173, 123, 28 and 5 families, one, two, three and four affected children were recruited, respectively. The ascertainment strategy and inclusion criteria have been described previously. 3 However, for the current study, trios (one affected child and both parents) were also included in addition to families with at least two affected siblings; single parents with affected children and half-sibs were excluded. Furthermore, as another distinction from the sample reported by Hebebrand et al.
3 DSM-IV diagnosis of ADHD in children from Homburg and Trier (n = 72) was derived from a semi-structured standardized interview with parents (Kinder-DIPS 43 ) and the Conners' Parent and Teacher Rating Scales. All families were of Caucasian descent; the vast majority of families were of German origin. A majority of the children had the combined type, and as usual, most of those children with the predominantly inattentive or predominantly hyperactive-impulsive type also fulfill some criteria of the other subtype (mean number of symptoms 2.6 and 3.9). Thus the sample is phenotypically relatively homogeneous, reflecting the whole range of ADHD symptoms.
Genotyping
For SNP selection, we used two main approaches: First, we selected DAT1-SNPs described in the literature either (1) to be associated with ADHD (rs6347, rs8179029, rs11564774 39, 44 ) or (2) to be functionally relevant for gene expression (rs3756450, rs2652510, ss35032437, rs2550956, rs11564752, rs1316830 25 ). Second, we selected from HapMap (www.hapmap.org, freeze October 05) 14 SNPs in an average density of 1 SNP per 4 kb that were validated in a Caucasian population and had a minor allele frequency (MAF) of > 0.08; these included all DAT1 tagging SNPs of the October 2005 freeze. Together, these SNPs cover the whole gene plus 5 0 flanking region ( Table 2) . Two SNPs (rs40184 and rs2617605) failed in the genotyping process and were excluded from further analyses.
GOOD assay. Genotyping of SNPs rs27072, rs11133767, rs6347, rs464049, rs403636, rs8179029 and rs7732456 was performed using the GOOD assay and matrix assisted laser disorption/ionisation (MALDI) mass spectrometry negative ion mode detection. 45, 46 Polymerase chain reaction (PCR), primer extension, phosphodiesterase II digestion, alkylation and sample preparation were performed as described 46, 47 TaqMan and resequencing SNPs rs37022, rs2042449, rs463379, rs6350 and ss11564774 were genotyped using TaqMan assays (Applied Biosystems, Foster City, CA, USA) using FAM and VIC reporter dyes. All TaqMan probes and primers were purchased from Applied Biosystems (assays on demand; www.appliedbiosystems.com). We used the ABI Prism 7900HT Sequence detection instrument (Applied Biosystems, Darmstadt, Germany) for thermocycling and data collection. Fragments DAT1 8, 10 and 11 (according to 25) were resequenced; these comprise SNPs rs11564752 (DAT 8), rs1316830 (DAT 10), rs3756450, rs2652510, ss35032437 and rs2550956. PCR and sequencing primers are listed in Supplementary Table 2 . Two microliters of genomic DNA (10 ng) was used as template for PCR. The amplicons were purified in 384-well plates and adjusted to similar molarity. DNA sequences were determined using ABI BigDye Terminator 3.1 chemistry and 3730 Â l ABI 96-capillary sequencer systems. Sequences were processed for quality clipping and assembled using an in-house software package based on the poly-phred system. 49 
Statistical analysis
Initially, marker data were checked for Mendelian inconsistencies using PedCheck 50 and in case of inconsistencies, the genotypes of all family members for the respective marker and family were set on missing. This resulted in the exclusion of one family due to several Mendelian errors. Thus, genotypes of 329 families with 523 affected children were available for the study, including the 102 families with 229 affected children analyzed in our previous genome scan (GS) 3 and 227 novel families with 294 affected children. Analyses were performed for the whole sample and the subsample of GS families (GS subset). Hardy-Weinberg equilibrium was checked on parental genotypes by w 2 -tests as implemented in Pedstats. 51 We checked for likely genotyping errors (e.g., manifesting as close double recombinants) using FAM-HAP 52 and set unlikely genotypes on missing for the respective individuals.
Haploview was used to calculate linkage disequilibrium (D 0 ) as a measure of pairwise LD and to create a graphical representation of the LD structure. 53 LD blocks were defined based on substantial pairwise LD only for the purpose of limiting the number of association tests performed (see below).
A family-based association test which is valid for families with an arbitrary number of affected children (basically a generalization of the Transmission Disequilibrium Test (TDT)) was performed for the 23 
Association and linkage of DAT1 variants to ADHD S Friedel et al
SNPs with a MAF > 3% in the DAT1 by using a permutation test 54 as implemented in FAMHAP. Transmitted and nontransmitted alleles are permutated independently for the affected children in one family, thus making this a test for linkage in the presence of association. To consider all possible haplotype configurations, this test was performed for all possible subsets of 2 to k markers in an LD block (that includes k markers); nominal P-values for the single marker tests and a global P-value that is corrected for all multiple testing performed are given. 55 For the most interesting markers, the genotype relative risk (GRR) of the homozygous and heterozygous carriers of the overtransmitted allele compared to homozygous carriers of the undertransmitted allele was estimated by conditional logistic regression. 56 The relative risk (RR) for haplotypes of markers 18-19-20 was calculated by defining the only overtransmitted haplotype (CGC) as the riskhaplotype and combining all other haplotypes into a group of nonrisk haplotypes.
Allele frequencies for linkage analysis (relevant only for the few missing parents) were estimated from all parental alleles. Multipoint nonparametric linkage analysis was performed on the qualitative affection status ADHD using the S all statistic 57 that can be converted to a nonparametric LOD score 58 as implemented in Merlin. 59 To follow up on our original finding 3 according to which our linkage finding on chromosome 5p mainly depended on the subscore for inattention, we also performed linkage analysis on the quantitative DSM-IV scores (total score, inattentive and hyperactive/impulsive subscores defined as the number of DSM-IV ADHD symptoms present, from the Kiddle-Sads-present and lifetime version (K-SADS-PL) using Merlin-regress 60 assuming a heritability of 0.6 and a population mean (variance) of 3 (2.5), 1.6 (1.5) and 1.4 (1.5), respectively, as determined previously in Germany. 61 Parametric linkage analysis under the same model as used in the GS was performed using Merlin. 62 We chose a dominant model since segregation analyses and the clinical observation that many parents also show symptoms of ADHD suggest such a mode of inheritance, but with reduced penetrance (0.6). We further used a phenocopy rate of 0.05 (close to the population prevalence) and a disease allele frequency of 0.01. The empirical significance of linkage results was assessed by Association and linkage of DAT1 variants to ADHD S Friedel et al simulating 10 000 replicates of our data under the null hypothesis of no linkage with the same characteristics regarding family structures, phenotypes, marker spacing and informativity. Post hoc analyses, as to whether the previously described evidence for nonparametric linkage to distal chromosome 5p could be explained by one of the investigated DAT1 polymorphisms, were performed both for the original 102 GS families 3 and the 156 families with affected sib pairs (ASPs). For this purpose, we used the genotype-IBD (identical by descent) sharing test (GIST), 62 which serves to investigate whether the allelic distribution of a polymorphism might be responsible for an observed linkage peak by testing whether probands with a certain genotype (under a dominant model) contributed more than expected to the linkage signal. To further investigate this question, we used the LAMP software 63 to test whether one of the SNPs is in complete or partial LD with a putative disease locus in this region, for example, whether it can explain the observed linkage. This was used without specifying a genetic model for the disease and was performed for the GS sample only, since the LAMP method performs best if additional, highly informative markers are genotyped.
Results
We investigated a total of 30 SNPs in the genomic region of DAT (Table 2) . We selected 19 SNPs by literature and HapMap; 11 variants were newly identified during resequencing of the 5 0 region (submitted to dbSNP).
Family-based single marker association tests
We tested every marker with a MAF > 0.03 for transmission disequilibrium as implemented in FAM-HAP. We observed five SNPs with nominal Pp0.05 ( Table 3 ). The lowest nominal P-value of 0.0002 was obtained for rs463379 (SNP20); upon conservative adjustment for all 23 tests (Bonferroni), the corrected P-value was significant (P = 0.0046). This corresponds to a GRR of 2.58 and 1.64 for homozygous and heterozygous carriers of the C allele compared to individuals with a GG genotype.
LD structure
Including all 23 markers with allele frequencies > 3%, we defined three HB. Block 1 includes marker 1-17, block 2 ranges from marker 19-23 and block 3 from marker 25-30. Linkage disequilibrium (D 0 ) between investigated SNPs is given in Figure 1 . The Association and linkage of DAT1 variants to ADHD S Friedel et al three HB were not completely independent of each other: SNP 21 is in strong LD with SNPs 3, 6, 7, 11 and 16 in block 1; whereas SNP 18 is in strong LD with SNP 30 in block 3. Also, not all SNPs are included in one of the blocks. The haplotype structure of DAT1 in our sample is comparable with the structure described by Greenwood et al. 24 in patients with bipolar disorder.
Family-based haplotype association tests
We obtained a global P-value for transmission disequilibrium of haplotypes within block 1 of 0.037 (corrected for 2047 tests). The global P-value for haplotypes in block 2 was 0.0016 (corrected for multiple testing of all 31 possible haplotype combinations). Haplotype block 3 also showed a modest association (global P-value, corrected for 62 tests: 0.0349). Because we tested three HB separately, a Bonferroni correction was performed. Following that correction, only block 2 had a significant effect (corrected P = 0.0048).
The marker combination in block 2 leading to the lowest nominal P-value of 0.000072 in the haplotype association test was 19-20. Inclusion of marker 18, which has only a weak correlation with block 2 revealed a global P-value of 0.0045 (corrected for 63 tests). In this case, the best marker combinations were 18-19-20 (nominal P = 0.000034) and 18-20 (nominal P = 0.000038) ( Table 4) .
Subset analysis for the marker combination 18-19-20 in the 102 families included in our previous genome-wide linkage scan (GS subset; 3 3 ) revealed a P-value of 0.00001. Exploratively, the GS subset was also analyzed further for combinations of markers [16] [17] [18] [19] [20] . We obtained a global P-value of 0.00071 (corrected for 31 tests), where combinations of markers 16-17 and markers 16-17-20 revealed best nominal Pvalues of 0.000004, followed by marker combination 16-17-19 (P = 0.000006).
The RR was estimated for haplotype CGC of markers 18-19-20 based on the total sample. Based on the observed 168 transmissions and 99 nontransmissions of the CGC haplotype, we estimated the relative risk for heterozygous carriers as 1.95, the 95% CI (confidence interval) ranged from 1.05 to 3.63 and for homozygous carriers as 2.43 (with 95% CI from 1.2 to 17.0). In the GS subset alone, we estimated a RR of 4.2 (95% CI from 1.45 to 12.15) for homozygotes of the CGC haplotype, whereas heterozygotes of the CGC haplotype showed a RR of 3.19 (95% CI from 1.28 to 7.94).
As the SNPs in the 5 0 flanking region were selected based on previously published functional findings, haplotypes described by Kelada et al. 25 were analyzed Association and linkage of DAT1 variants to ADHD S Friedel et al separately. Haplotype frequencies estimated from 1188 independent chromosomes were similar to frequencies described in the literature estimated from 48 chromosomes 25 (see Table 5 ). There was no association of the Kelada-haplotypes in our sample with ADHD (P = 0.198).
Nonparametric and parametric linkage analysis
For nonparametric linkage analysis in all families with at least one ASP (n = 156), we obtained the highest multipoint LOD score of 0.97 at SNP 19 (empirical P-value 0.02), the same SNP showed the highest HLOD (1.31, empirical P-value 0.009) for parametric linkage analysis under a dominant model. Upon restriction of the analysis to the 102 families in the GS subset, we also obtained the highest multipoint LOD score of 2.54 in proximity to SNP 19 (empirical P-value 0.0004) and the highest HLOD (3.05; empirical P-value 0.0003) for parametric linkage analysis under a dominant model. Our genotyped SNPs are jointly very informative for linkage in this region (multipoint information content 84-90%).
Quantitative linkage analysis
As described in our genome-wide scan, 3 we calculated LOD scores for the quantitative DSM-IV subtype scores. SNP 25 showed the highest multipoint LOD score (0.91) for the inattentive subscore, whereas the highest multipoint LOD score for the hyperactive/ impulsive subscore was 0.16 at SNP 30. The same SNP showed the highest multipoint LOD (0.60) score for DSM-IV total score. Additionally, we performed this analysis in the GS subset. 3 We obtained the highest multipoint LOD scores for SNP 19. We detected an LOD score of 1.95 for the inattentive subscore, followed by the DSM-IV total score with an LOD score of 1.54 and the hyperactive/impulsive subscore (0.20).
SNPs potentially explaining the observed linkage (GIST and LAMP analyses)
According to the GIST analysis, the genotypes observed for SNPs 8, 20, 22, 23, 25, 26 and 29 could be responsible for the linkage of ADHD to chromosome 5p in our sample: Under a dominant model, families whose affected children have specific genotypes at these SNPs contribute most of the evidence to the observed linkage peak ( Table 3) . As an example, for SNP 22, affected children with at least one T allele (corresponding to a dominant model) contributed significantly more than expected to the LOD score (GIST P-value 0.002). The same applies to SNP 23 (T allele, GIST P-value 0.002) and SNP 29 (C allele, GIST P-value 0.004). Under a recessive model, only SNP 23 reached significance (T allele, GIST P-value 0.03). For an additive model, the T allele of SNP 22 and the T allele of SNP 23 contributed more than expected to the LOD score (GIST P-values 0.02 and 0.004). In the GS subset alone, which showed much stronger linkage, the genotypes observed for SNPs 3, 11, 14, 22, 23 and 29 could be responsible for the evidence for linkage on chromosome 5p (Pp0.05). Investigating the same issue with a different approach, the LAMP results also suggest that DAT1 SNPs are in strong LD with the putative causal variant (or could be identical to this): especially SNP 18 showed a highly significant P-value of 0.0008, while a few other SNPs showed weak evidence with P < 0.1.
Discussion
In view of the linkage of ADHD to distal chromosome 5p and functional data implicating DAT1 in the etiology of this disorder, we analyzed this plausible candidate gene located at 5p15.33 (1.45-1.50 Mb) for both association and linkage. For this purpose, we genotyped a total of 30 SNPs which covered the CDS and the 5 0 flanking region (from À4935 to 50 348 bp in relation to the ATG) in 329 nuclear families with one or more affected children including 102 families (GS subset), who were previously included in a genomewide linkage scan. 3 In this scan our initial nonparametric LOD score value of 2.89 next to the marker D5S2005 (1.40 Mb) was obtained within a broad peak extending from the distal end of 5p to beyond 60 cM; our subsequent fine-mapping efforts resulted in a nonparametric LOD score of 2.78 at 17 cM. 3 Ogdie et al. 6 localized their 5p peak in 308 ASPs to 59 cM (MLS (maximum LOD score) 2.55), whereas Bakker et al. 64 reported an MLS of 1.43 at 69 cM in 164 ASPs. In light of the small sample sizes, which lead to considerable stochastic variation of the location of linkage peaks, 65 it seems plausible to assume that genetic variation at the same locus (or loci) underlies these chromosome 5p linkage peaks.
DAT1 has repeatedly been analyzed for association to ADHD. Particularly, the results for a VNTR at the 3 0 prime end of the gene have been conflicting; recent meta-analyses have not been able to substantiate this association. 37, 38 Very recently, Brookes et al. 41 analyzed 32 DAT1 SNPs in 776 combined type ADHD cases and their parents and reported association (nominal Pp0.05) with four SNPs in the 5 0 region. There was no association reported for our significant haplotype-SNPs ( SNPs 18, 19 and 20) . However, in the respective study, a total of 51 candidate genes were analyzed using 1038 SNPs; none of the reported associations were significant upon correction for multiple testing. Repeated mutation screens and resequencing efforts have shown that nonsynonymous DAT1 SNPs are too infrequent to explain the ADHD linkage signal on 5p. [27] [28] [29] [30] We summarize the major findings of our current study: (1) rs463379 (SNP 20) located in intron-4of DAT1 was significantly associated with ADHD (P = 0.0046) in our 329 families upon correction for multiple testing. (2) Furthermore, the global P-value for association to haplotypes in block two, which includes intron 4, was significant upon correction for all three tested blocks (P = 0.0048). (3) Our three HB are comparable with blocks described elsewhere. 24, 41 Within block two, the best marker combination was 18-19-20 (nominal P = 0.000034). The CGC haplotype of showed substantial relative risks of 1.95 for heterozygous carriers and 2.43 for homozygous carriers in the whole family sample. (4) Finally, our linkage data and the GIST and LAMP analyses indicate that genetic variation at the DAT1 locus at least partially explains our linkage peak. 3 We applied nonparametric and parametric multipoint linkage analysis to 23 SNPs. Subsequent GIST and LAMP analyses revealed that SNP 18 (LAMP P-value 0.0008) and SNP 20 (GIST P-value 0.004) of the haplotype 18-19-20 contribute significantly to the linkage signal. Altogether, the GIST and LAMP analyses do not prove that our most strongly associated haplotype 18-19-20 is responsible for the linkage signal, but it clearly supports our hypothesis that genetic variation at the DAT1 locus contributes to the linkage signal on chromosome 5p. However, both methods assess whether particular DAT1 SNPs can explain the linkage observed at the DAT1 region (around 2 cM); we cannot make any inference to the originally highest peak around 17 cM:
3 LAMP assumes no recombination between a putative causal locus and the tested SNP, whereas GIST evaluates the contribution of families with specific genotypes in the affected children to the observed LOD score within a particular region. Thus, we cannot exclude that other genes may also contribute to our original linkage at 17 cM 3 and to the peaks on 5p found by other groups. 6, 64 In general, all of the aforementioned findings were stronger in the GS subset. The 54 new families, which included affected sib pairs thus allowing linkage analysis, did not show such a strong linkage as the original 102 GS families. In accordance with our previous linkage finding, 3 we obtained the highest LOD score for the inattentive subscore, the LOD score for the hyperactivity/impulsivity subscore was considerably lower, the total score being intermediate. Several different reasons may contribute to the fact that the novel 227 families did not substantially contribute to the association and linkage. In 173 of these families, only one child with ADHD was ascertained. In the GS subset, all families included at least two affected ones. We thus cannot exclude the possibility that differences in ascertainment (affected sib-pairs versus singletons) contributed to the discrepancy. Alternatively, it may well be that the original effects were overestimated by a phenomenon known as the 'winner's curse'. We have already pointed out that the functionally relevant SNP/ haplotype might have been missed in our study; conceivably such an as yet untested DAT1 SNP/ haplotype might cast light on the observed differences between our two subsamples. Furthermore diagnostic discrepancies cannot totally be excluded as a contributing factor due to the use of two different diagnostic schemes at the participating child and adolescent psychiatric departments for the DSM-IV diagnosis of ADHD. However, as all interviews were conducted by physicians trained in child and adolescent psychiatry and experienced in ADHD and as the majority of cases of the new families were diagnosed in the same way as the GS subset we do not think that diagnostic issues play a major role; an impact of comorbid conditions cannot be excluded. Murine QTL studies have implicated trans-acting variation in Dat1 expression levels; 66 if trans-acting variation also plays a role in humans, this could potentially contribute to our observation of a stronger effect in the GS subset. In light of our low P-values and previous findings implicating DAT1 in the genetic etiology of ADHD, we consider false positive results highly unlikely.
Our findings are in line with other studies describing association of single markers or haplotypes of the DAT1 gene with ADHD and related phenotypes. 41, 67 Lasky-Su et al. 67 described nominal association of six SNPs with quantitative phenotypes generated from variables pertaining to the frequency of drug intake in ADHD patients in a haplotype block overlapping with our haplotype block two. The analysis of 51 candidate genes for ADHD in a worldwide sample of 776 DSM-IV combined type cases revealed positive association of a haplotype constructed from the 3 0 VNTR and a VNTR in intron 8 and additional six SNPs with P < 0.05 in 5 0 and 3 0 flanking regions, 41 overlapping either with our haplotype block one or haplotype block three. Interestingly, in the supplementary material presented by Brookes et al., 41 the only haplotype showing a trend toward association (best nominal P = 0.075) consisted of five SNPs located in a region equivalent to our haplotype block two and includes our haplotype SNPs 19 and 20. Given this consistent overlap, which is rarely seen in association analyses of complex psychiatric disorders, we are indeed confident that the association to ADHD of DAT1 SNPs and haplotypes is real. In this context, it is even conceivable that the positive 3 0 VNTR (reviewed in Purper-Ouakil et al. 37 and Li et al. 38 ) association studies do not represent false positives. The 3 0 VNTR is located in exon 15; interestingly SNP 18 (exon 2) in haplotype block 2 shows linkage disequilibrium to SNP 30; the location of the 3 0 VNTR is only 778 bp 5 0 to SNP 30. From our data, it is not possible to exactly determine which DAT1 SNP or haplotype is relevant in functional terms. We had genotyped SNPs forming distinct haplotypes that had previously been associated with different DAT1 expression levels. 25 However, we found no evidence for involvement of these haplotypes in the etiology of ADHD in our sample. A very recent study, however, reported on a core haplotype based on an intron 1 SNP ( þ 1821G > A; rs2937639) and a 5 0 flanking SNP (À841C > T; rs2652511) to be associated with variation in DAT1 expression levels in in vivo and post-mortem studies. 26 These results encourage further in-depth sequencing of this genomic region in order to capture the entire genetic variation.
We performed extensive in silico analyses in an attempt to detect functional implications of SNPs 18, 19 and 20. As SNP 18 is a synonymous mutation and SNPs 19 and 20 are located within introns 2 and 4, respectively, we found no obvious functional implications. Neither splice sites 68 nor transcription factor binding sites 69 are affected and the variants do not introduce cryptic splice sites. Due to the fact that the functional variant might be in close LD with one of the haplotype SNPs, we had a further look at a total of 153 SNPs found in dbSNP (http://www.ncbi.nlm. nih.gov/SNP/) between SNPs 17 and 21. The SNP density is high in that region (8 SNPs/kb as compared to a usual genome-wide density of approximately 1 SNP/kb; 70 ). Our in silico analyses again revealed no plausible functional implications for any of these SNPs.
The observed DAT1 LD blocks do not exclude the possibility that single SNPs (or haplotypes) show LD to regions outside the approximately 55 kb covered by our 30 SNPs. Indeed, single SNPs in one of the three HB were also in strong LD to other blocks. Accordingly, functionally relevant regulatory sequences 5 0 or 3 0 to our analyzed sequence could underlie the association observed at SNP 20 or the haplotypes 18-19-20.
In conclusion, we found both association and linkage of SNPs and haplotpyes in DAT1 to ADHD; these findings explain our linkage peak on chromosome 5p obtained for a subset of the 329 families analyzed in the current study. Association of SNP 20 and association of linkage disequilibrium block two haplotypes were significant upon corrections for multiple testing; single haplotypes in block two revealed exceedingly low nominal P-values. There are several possible explanations why the association and linkage are more pronounced in the original 102 families who had previously served as the basis of our genome-wide scan. In addition, we do not have functional data related to our molecular genetic findings. Nevertheless, our significant results represent the strongest data yet implicating DAT1 in the etiology of the most common childhood psychiatric disorder.
